Navigation Links
MiMedx Group Announces Third Quarter 2011 Results
Date:10/26/2011

 We hope to be able to consummate additional OEM transactions during the fourth quarter," added Petit.

During the quarter, MiMedx submitted its initial request for Medicare reimbursement for EpiFix®. The Company reported that its data and information are currently undergoing a review, and MiMedx hopes to have some positive answers in the months ahead.  "If we can obtain Medicare coding in certain facilities for our AmnioFix® and EpiFix®, it should quickly open up new sites that would be interested in our innovative allografts," commented Taylor.

The Company completed the final phase of the relocation of its headquarters and manufacturing facilities during the quarter. The Company now has the majority of its employees in one facility in Kennesaw, Georgia. We expect that we will receive the European CE Mark for the Company's CollaFix™ surgical mesh product during the fourth quarter. With our manufacturing consolidation behind us, we are well prepared to ramp up our production to meet the anticipated demand for CollaFix™ in Europe," concluded Taylor.

Earnings CallMiMedx management will host a live broadcast of its third quarter conference call today, Wednesday, October 26, 2011, beginning at 10:30 a.m. eastern time.  A listen-only simulcast of the MiMedx Group conference call will be available online at the Company's website at www.mimedx.com or at www.earnings.com.  A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast.  The replay can also be found on the Company's website at www.mimedx.com or at www.earnings.com.

About the CompanyMiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. MiMedx Groups EpiFix® Receives American Podiatric Medical Association Seal of Approval
2. MiMedx Group Partners With Affirmative Solutions
3. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
4. MiMedx Announces Launch of AmnioFix™ Nerve Wrap
5. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
6. MiMedx Group, Inc. Announces Release Date for First Quarter Results
7. MiMedx Completes Acquisition of Surgical Biologics
8. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
9. MiMedx Announces Agreement to Acquire Surgical Biologics
10. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
11. MiMedx Group Announces Addition of Sales Director for Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
(Date:3/27/2015)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... registered offering of common shares in the ... Offering, the Company issued 7,286,432 common shares at a ... of approximately $1.45 billion. On March 18, 2015, the ... a final prospectus supplement to its effective shelf registration ...
(Date:3/27/2015)... HOLLYWOOD, Calif. , March 27, 2015 ... of life of myeloma patients while working toward prevention ... Higgins (D-NY) for introducing a federal resolution (H. ... of March 2015 as "National Multiple Myeloma Awareness Month." ... living with myeloma worldwide, and more than 110,000 new ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... NEW YORK , June 24 Reportlinker.com announces that a new market research ... , Global Bipolar Disorder ... http://www.reportlinker.com/p0209267/Global-Bipolar-Disorder-Industry.html , ... This report analyzes the worldwide markets for Bipolar Disorder in US$ Million. The report ...
... ALEXANDRIA, Egypt and NORCROSS, Ga. , June ... distribution company, today announced that it has signed an exclusive agreement ... Pharmaplast. , , , ... milestone agreement is the foundation for MediPurpose,s recently launched Wound Care ...
Cached Medicine Technology:Reportlinker Adds Global Bipolar Disorder Industry 2Reportlinker Adds Global Bipolar Disorder Industry 3Reportlinker Adds Global Bipolar Disorder Industry 4Reportlinker Adds Global Bipolar Disorder Industry 5Reportlinker Adds Global Bipolar Disorder Industry 6Reportlinker Adds Global Bipolar Disorder Industry 7Reportlinker Adds Global Bipolar Disorder Industry 8Reportlinker Adds Global Bipolar Disorder Industry 9Reportlinker Adds Global Bipolar Disorder Industry 10Reportlinker Adds Global Bipolar Disorder Industry 11Reportlinker Adds Global Bipolar Disorder Industry 12Reportlinker Adds Global Bipolar Disorder Industry 13Reportlinker Adds Global Bipolar Disorder Industry 14Reportlinker Adds Global Bipolar Disorder Industry 15Reportlinker Adds Global Bipolar Disorder Industry 16MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 2MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 3MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 4
(Date:3/27/2015)... NY (PRWEB) March 27, 2015 Ticket Down is ... Concert in 2015. After a phenomenal and highly successful ... "Nashville" will be going out on tour again in 2015 and ... tour gets underway on April 29th in New York City at ... at the Comerica Theatre on May 10th. , Fans of the ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 DrugDev ... Melissa (Liss) Easy was named to the 2015 Philadelphia ... Under 40 list spotlights 40 dynamic, up-and-coming leaders less ... and community involvement. Winners are honored at an awards ... of the Philadelphia Business Journal. , Lyn Kremer, Publisher ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 GenSight, the ... has appointed Sean Fitzgerald, a former technology and financial ... Officer and Interim Chief Financial Officer. , Mr Fitzgerald ... technology innovator, EverFi, backed by Amazon founder and CEO ... Evan Williams. Prior to EverFi, he was a Senior ...
(Date:3/27/2015)... March 27, 2015 Operatic contenders and ... greatness on April 17th. The universally acclaimed baritone Sherrill ... 9th annual Opera Idol at The Merion in Evanston. ... which has drawn aspiring opera singers from around the ... some of the finest young talent in the country,” ...
(Date:3/27/2015)... 27, 2015 Since September 2014, the country ... comeback tour after having been in retirement for a period ... the performer to return to touring, and concert events have ... Omaha will likely sell out for the two shows recently ... to view the inventory of discounted Garth Brooks tickets ...
Breaking Medicine News(10 mins):Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2
... Inc.,(OTC Bulletin Board: ENEI) today announced that its ... presentation at the Roth,Capital 20th Annual OC Growth ... February 21st. The conference is being held over ... Dana Point, California. The,conference will feature presentations from ...
... /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that for the year ... million, or 62 cents per share, on revenues of $31.8,million ... cents per share, on,revenues of $27.6 million in the previous ... posted a net loss of $26.8 million, or 28,cents per ...
... interpersonal conflicts had more health problems, study found , , FRIDAY, ... along with others is more than a key to pleasant ... health. , Researchers who studied a survey of almost ... their relatives, friends and neighbors were less likely to report ...
... Webcast on February 21st at 12:00 p.m. Pacific Time ... (Amex: SYI ) announced today that Noah Berkowitz, ... present at,the Roth 20th Annual OC Growth Stock Conference ... (3:00 p.m. Eastern time) at the Ritz,Carlton Hotel in ...
... international study published today finds that some alternative therapies ... choices for managing most common neck pain than many ... best options for relief are exercises, education, neck mobilization, ... such as neck collars and ultrasound are not recommended. ...
... concept that chronic pain is a disease in its ... at physical, psychological, and environmental components of this major ... pain medicine expert. , Michael J Cousins AM, MD, ... Institute at the University of Sydney, Royal North Shore ...
Cached Medicine News:Health News:Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference 2Health News:Westaim announces 2007 year-end results 2Health News:Westaim announces 2007 year-end results 3Health News:Westaim announces 2007 year-end results 4Health News:Westaim announces 2007 year-end results 5Health News:Westaim announces 2007 year-end results 6Health News:Westaim announces 2007 year-end results 7Health News:Westaim announces 2007 year-end results 8Health News:Westaim announces 2007 year-end results 9Health News:Westaim announces 2007 year-end results 10Health News:Westaim announces 2007 year-end results 11Health News:Westaim announces 2007 year-end results 12Health News:Unlike Fine Wine, Crabby People Don't Age Well 2Health News:Unlike Fine Wine, Crabby People Don't Age Well 3Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3Health News:7-year neck pain study sheds light on best care 2Health News:7-year neck pain study sheds light on best care 3Health News:7-year neck pain study sheds light on best care 4Health News:Chronic pain should be considered a disease 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
200 L, Bulk, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. ...
Its generous filter placement, MicroPoint design, and reference marks at 10, 50, and 100 ul make this ART tip ideal for many 200 ul pipettors....
... tips, microfuge tubes and PCR tubes. ... RNase- and DNase-free. Tubes have a ... 120°C. Available in a variety of ... a low binding surface. PCR Tubes ...
Medicine Products: